An AI-driven digital medicine platform, called Quadratic Phenotypic Optimisation Platform (QPOP), developed by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at NUS is helping doctors make better clinical decisions when treating cancer patients. Associate Professor Edward Chow (right) is the leader of the team that developed QPOP and a principal investigator at the Department of Pharmacology, National University of Singapore
